Combining Light Therapy and CPAP in Depression
Effects of Light Therapy on Compliance With Continuous Positive Airway Pressure in a Population of Depressed Patients Newly Fitted With Devices for Obstructive Sleep Apnea
Hôpital le Vinatier
130 participants
Jan 17, 2025
INTERVENTIONAL
Conditions
Summary
In a double-blind, parallel-group controlled trial, we aim to measure the effect of two weeks of light therapy combined with the CPAP on compliance CPAP in patients with major depressive disorder.
Eligibility
Inclusion Criteria3
- Adults consulting at the MICHEL JOUVET unit, CH Le Vinatier, Bron
- Adults with a diagnosis of major depressive episode (DSM-V) and with a MADRS score ≥ 15
- Adults with a diagnosis of OSAS on ventilatory polygraphy or polysomnography (AASM 2017 criteria) requiring CPAP.
Exclusion Criteria10
- Refusal to participate.
- Pregnant and breast-feeding women
- Under guardianship or curatorship.
- Unstable psychiatric or physical pathology (e.g., hypomania, high suicidal risk) considered incompatible with the study by the investigators.
- Other psychiatric, neurologic or somatic conditions
- Contraindication to light therapy: retinopathy, retinitis pigmentosa, diabetic retinopathy, macular degeneration, glaucoma, recent eye surgery (less than 3 months).
- patient wishing to choose a provider other than the protocol provider.
- Patient wishing to choose a device other than SEFAM's S-BOX or a mask other than the nasal mask at the time of introduction.
- Nasal obstruction.
- Refusal to use actimetry, refusal to use light therapy, refusal to use CPAP.
Interventions
The intervention consists of 30 minutes of daily exposure to light therapy glasses (active or sham according to randomization) on waking for 2 weeks. The light therapy will be delivered in the patient's home at the same time as CPAP is introduced.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06781593